
US-based pharmaceutical giant Eli Lilly will invest more than USD 1bn in a new factory in Concord, North Carolina.
The facility will produce injectible products, and is expected to provide around 600 jobs, Eli Lilly announces in a press release.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app